Skip to main content
Quest Diagnostics

Development of a Semi-Quantitative Liquid Chromatography Tandem Mass Spectrometry Method for 62 Drugs in Umbilical Cord Tissue

SOFT 2024

Society of Forensic Toxicologists

St Louis, MO Oct 27-31, 2024

Oral presentation: Development of a Semi-Quantitative Liquid Chromatography Tandem Mass Spectrometry Method for 62 Drugs in Umbilical Cord Tissue

Authors: Evans TR, Dui W, Bartock SH

Specialty: Prescription Drug Monitoring, Toxicology, Women's Health, Pediatrics

Related content

Conference Presentation
Simultaneous Quantitation and Discovery (SQUAD) Metabolomics: An Intelligent Combination of Targeted and Untargeted Mass Spectrometry Workflows for Drug Toxicology
Audio Podcast
Drug Testing for Stimulants
Test FAQ
Chromosome Analysis, POC Tissue
On-Demand Webinar
Innovative Solutions: LC-MS/MS

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.